3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
6
Rectal Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Spinal Cord Tumor of Cervical Spine
1
Prostatic Neoplasms
1
Pelvic Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Hypoxia
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma in Situ
1
Biliary Tract Neoplasms
1
Anus Neoplasms
1
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
2
fluoroazomycin arabinoside
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Injections
1
Drug Therapy
1
Diagnostic Imaging
1
Blood Specimen Collection
1
AQ4N
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
Magnetic Resonance Imaging
×
Gynecologic
×
Clear all
NCT05029258
2026-05-12
Bio-CHECC
University of Manchester
Active not recruiting
30 enrolled